Skip to main content
TXMD logo
TXMD
(NASDAQ)
TherapeuticsMD, Inc.
$2.06-- (--)
Loading... - Market loading

TherapeuticsMD (TXMD) Company Profile

Complete business overview, executive team, trading details, and corporate information.

TherapeuticsMD, Inc.
TXMDNasdaq Stock MarketHealthcareDrug Manufacturers - Specialty & Generic

About TherapeuticsMD

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone561-961-1900
Address
951 Yamato Road, Suite 220 Boca Raton, Florida 33431 United States

Corporate Identifiers

CIK0000025743
CUSIP88338N206
ISINUS88338N2062
EIN87-0233535
SIC2834

Leadership Team & Key Executives

Marlan D. Walker J.D.
Chief Executive Officer
Joseph A. Ziegler
Principal Financial and Accounting Officer